ALS-008176

· Alios Biopharma Inc.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for ALS-008176, covering 2016-07-11 to 2025-02-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus [Phase 2]

See pricing